ACHE and Alzheimer disease: In addition, the levels of butyrylcholinesterase (BChE) are increased in AD patients as compensation of a reduced expression of acetylcholinesterase (AChE) and the inhibition activity, exerted on both enzymes by flavan-3-ol compounds, gives these molecules renewed interest in the prevention strategies of the most seriously disabling neurodegenerative illness.